SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway in Market Cap on Debut Trump Seeks Independence in Next Fed Chair Amid History of Rate Cut Pressure CapitaLand Unveils 14 Billion Life Sciences Hub Geneo at Science Park BP Chairman Abruptly Removed Amid Allegations of Bullying and Overbearing Conduct Reddit Shares Slide Nearly 6 on Metas Launch of Competing Forum App The Pitfalls of Performance Chasing Why LongTerm Strategy Matters Over ShortTerm Returns PLBY Q1 2026 Earnings Significant EPS Miss Amidst Strategic Transformation Park Hotels Resorts Q1 2026 Earnings EPS Surprises by 7696 Amid Rebounding Travel Demand FHN Q1 2026 Earnings EPS Beats Estimates by 623 as Stock Edges Higher STEL Q1 2026 Earnings Strong EPS Beat Amid Marginal Stock Decline CalMaine Foods Q1 2026 Earnings EPS Surges Past Estimates on Stable Egg Demand Hudbay Minerals Q1 2026 Earnings EPS Beats Estimates Amid Copper Price Support Stock Slips Gates Industrial GTES Slides 326 as Selling Pressure Intensifies Invesco Quality Municipal Income Trust IQI Edges Higher on Modest Gains Carlyle Credit Income Fund CCIF Dips 22 Key Support Levels in Focus Ambarella AMBA Drops Nearly 5 Testing Key Support at 8455 Investors Title Company ITIC Edges Down as Support Levels Come Into Focus Tony Blairs Economic Diagnosis Hits Mark but AIFocused Prescription Draws Skepticism RadNet Inc RDNT Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Texxon Holding NPT Under Pressure Support Test Looms After 216 Decline Septerna Inc SEPN Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Response ConAgra Brands Q1 2026 Earnings EPS Misses Estimates Amid Cautious Market Reaction The RealReal Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline GREEL Q1 2025 Earnings Narrower Loss Surpasses Estimates as Senior Notes Remain Stable SLG Q1 2026 Earnings EPS Misses Amid Market Volatility Stock Rises on Operational Resilience Adamas Trust ADAML Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat on FixedtoFloating Rate Structure Enanta Pharmaceuticals ENTA Q1 2026 Earnings NarrowerThanExpected Loss Eases NearTerm Concerns